Download PDFPDF

1144 MHC II neoantigen vaccines improve antitumor immunity and response to immune checkpoint inhibitor in cold tumor
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address